MedMira Inc Asset Resilience Ratio

Latest as of October 2002: 3.09%

MedMira Inc asset resilience ratio. MedMira Inc (MIR) has an Asset Resilience Ratio of 3.09% as of October 2002. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MIR defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CA$73.82K

≈ $53.40K USD Cash + Short-term Investments

Total Assets

CA$2.39 Million

≈ $1.73 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of MedMira Inc (2001–2002)

Asset resilience ratio of MedMira Inc from 2001 to 2002. This chart shows how MedMira Inc's Asset Resilience Ratio has changed over time. Read debt load of MedMira Inc for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down MedMira Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MedMira Inc asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$73.82K	3.09%
Total Liquid Assets	CA$73.82K	3.09%

Asset Resilience Insights

Limited Liquidity: MedMira Inc maintains only 3.09% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

MedMira Inc Industry Peers by Asset Resilience Ratio

Compare MedMira Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
Genmab A/S CO:GMAB	Biotechnology	23.50%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	Biotechnology	1.69%
Abivax SA American Depositary Shares NASDAQ:ABVX	Biotechnology	4.91%
Bachem Holding AG SW:BANB	Biotechnology	0.00%
Viking Therapeutics Inc NASDAQ:VKTX	Biotechnology	72.03%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%

MedMira Inc Asset Resilience Ratio by Year (2001–2002)

MedMira Inc asset resilience ratio by year from 2001 to 2002. The table below shows the annual Asset Resilience Ratio data for MedMira Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2002-07-31	2.20%	CA$73.82K ≈ $53.40K	CA$3.36 Million ≈ $2.43 Million	-0.19pp
2001-07-31	2.39%	CA$72.35K ≈ $52.33K	CA$3.03 Million ≈ $2.19 Million	--

pp = percentage points

About MedMira Inc

V:MIR Canada Biotechnology

Market Cap

$25.38 Million

CA$35.09 Million CAD

Market Cap Rank

#24183 Global

#895 in Canada

Share Price

CA$0.05

Change (1 day)

+0.00%

52-Week Range

CA$0.05 - CA$0.08

All Time High

CA$0.70